The production of vaccines against viral infections is becoming increasingly important as it can prevent the mass spread of infections. Vaccines are made from virus-like particles, live-attenuated viruses, dead virus particles, purified virus parts, viral vector vaccines and nucleic acid vaccines. Viruses, as a main part of vaccines, are divided into helical, icosahedral, complex and enveloped viruses. Enveloped viruses present a major challenge for their characterisation and isolation, due to non-specific interactions caused by the lipid bilayer. With the correct order of known separation techniques we want to achieve the cleanest, most cost-effective and competitive product on the vaccine market and to reduce side effects with the patient.
|
